Clearbridge BioMedics is the first Asian biotechnology company to join the CANCER-ID consortium for blood-based biomarker evaluation.
Scientists have replaced blood agar plates with flurophores for detecting hemolytic bacteria.
Scientists in Taiwan have developed a paper-based, smartphone-readable test for the detection of tuberculosis infection.
IBM Watson is changing the practice of healthcare in both hospitals and homes with its ability to learn and apply huge volumes of information.
NTU Singapore and NNI are collaborating to bring engineers and clinicians under one roof to conduct research on neurological diseases.
Scientists have used brain imaging techniques to replace invasive biopsies in diagnosing kidney diseases.
Detecting cancers with a blood test sounds simple enough, but is it just hype or are liquid biopsies here to stay?
Researchers have used conducting polymers to develop a flu virus detector that is faster and a hundred times more sensitive than commercially available tests.
GRAIL and Cirina have entered an agreement to form a global company focused on the early detection of cancer.